XML 25 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Change in Shareholders' Deficit - USD ($)
Total
Previously Reported [Member]
Additional Paid-In Capital
Additional Paid-In Capital
Previously Reported [Member]
Accumulated Deficit
Accumulated Deficit
Previously Reported [Member]
Class A Ordinary Shares
Ordinary Shares
Class A Ordinary Shares
Ordinary Shares
Previously Reported [Member]
Class B Ordinary Shares
Ordinary Shares
Class B Ordinary Shares
Ordinary Shares
Previously Reported [Member]
Balance at Dec. 31, 2020 $ 19,506   $ 24,137   $ (5,494)       $ 863  
Balance (in Shares) at Dec. 31, 2020                 8,625,000  
Sale of 34,500,000 Units on March 2, 2021 through public offering 3,450           $ 3,450      
Sale of 34,500,000 Units on March 2, 2021 through public offering (in Shares)             34,500,000      
Excess of the fair value of private placement warrants over cash received 1,880,000   1,880,000              
Class A ordinary shares subject to possible redemption (3,450)           $ (3,450)      
Class A ordinary shares subject to possible redemption (in Shares)             (34,500,000)      
Remeasurement of Class A ordinary shares subject to possible redemption (28,950,644)   (1,904,137)   (27,046,507)          
Net income 5,128,650       5,128,650          
Balance at Dec. 31, 2021 (21,922,488)   0   (21,923,351)   $ 0   $ 863  
Balance (in Shares) at Dec. 31, 2021             0   8,625,000  
Net income 1,295,281   0   1,295,281   $ 0   $ 0  
Balance at Mar. 31, 2022 (20,627,207)   0   (20,628,070)   $ 0   $ 863  
Balance (in Shares) at Mar. 31, 2022             0   8,625,000  
Balance at Dec. 31, 2021 (21,922,488)   0   (21,923,351)   $ 0   $ 863  
Balance (in Shares) at Dec. 31, 2021             0   8,625,000  
Net income   $ 3,321,266                
Balance at Jun. 30, 2022   (18,781,440)                
Balance at Dec. 31, 2021 (21,922,488)   0   (21,923,351)   $ 0   $ 863  
Balance (in Shares) at Dec. 31, 2021             0   8,625,000  
Net income   6,726,111                
Balance at Sep. 30, 2022   (16,803,964)                
Balance at Dec. 31, 2021 (21,922,488)   0   (21,923,351)   $ 0   $ 863  
Balance (in Shares) at Dec. 31, 2021             0   8,625,000  
Accretion portion net against additional paid-in-capital (592,600)   (592,600)              
Proceeds received on convertible note less than fair value 592,600   592,600              
Remeasurement of Class A ordinary shares subject to possible redemption (4,334,713)   (2,727,125)   (1,607,588)          
Reduction of deferred underwriting fee payable 8,784,563   8,784,563              
Net income 5,982,340       5,982,340          
Balance at Dec. 31, 2022 (11,490,298) (11,490,298) 6,057,483 $ 6,057,438 (17,548,599) $ (17,548,599)   $ 0 $ 863 $ 863
Balance (in Shares) at Dec. 31, 2022               0 8,625,000 8,625,000
Balance at Mar. 31, 2022 (20,627,207)   0   (20,628,070)   $ 0   $ 863  
Balance (in Shares) at Mar. 31, 2022             0   8,625,000  
Net income   2,025,986                
Balance at Jun. 30, 2022   (18,781,440)                
Balance at Dec. 31, 2022 (11,490,298) $ (11,490,298) 6,057,483 $ 6,057,438 (17,548,599) $ (17,548,599)   $ 0 $ 863 $ 863
Balance (in Shares) at Dec. 31, 2022               0 8,625,000 8,625,000
Accretion of Class A ordinary shares subject to possible redemption (4,017,216)   (4,017,216)       $ 0   $ 0  
Proceeds received on convertible note less than fair value 12,198   12,198   0   0   0  
Net income 170,155   0   170,155   $ 0   0  
Balance at Mar. 31, 2023 $ (15,325,161)   $ 2,052,420   $ (17,378,444)       $ 863  
Balance (in Shares) at Mar. 31, 2023                 8,625,000